Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Benefit of Early Add-on of Linagliptin to Insulin in Japanese Patients With Type 2 Diabetes Mellitus: Randomized-Controlled Open-Label Trial (TRUST2).
Katsuno T, Shiraiwa T, Iwasaki S, Park H, Watanabe N, Kaneko S, Terasaki J, Hanafusa T, Imagawa A, Shimomura I, Ikegami H, Koyama H, Namba M, Miyagawa JI; TRUST2 study group. Katsuno T, et al. Among authors: shiraiwa t. Adv Ther. 2021 Mar;38(3):1514-1535. doi: 10.1007/s12325-021-01631-y. Epub 2021 Jan 28. Adv Ther. 2021. PMID: 33507500 Clinical Trial.
Beneficial effects of nateglinide on insulin resistance in type 2 diabetes.
Hazama Y, Matsuhisa M, Ohtoshi K, Gorogawa S, Kato K, Kawamori D, Yoshiuchi K, Nakamura Y, Shiraiwa T, Kaneto H, Yamasaki Y, Hori M. Hazama Y, et al. Among authors: shiraiwa t. Diabetes Res Clin Pract. 2006 Mar;71(3):251-5. doi: 10.1016/j.diabres.2005.08.004. Epub 2005 Oct 7. Diabetes Res Clin Pract. 2006. PMID: 16214255 Clinical Trial.
The impact of new-onset diabetes on arterial stiffness after renal transplantation.
Kato K, Matsuhisa M, Ichimaru N, Takahara S, Kojima Y, Yamamoto K, Shiraiwa T, Kuroda A, Katakami N, Sakamoto K, Matsuoka TA, Kaneto H, Yamasaki Y, Hori M. Kato K, et al. Among authors: shiraiwa t. Endocr J. 2008 Aug;55(4):677-83. doi: 10.1507/endocrj.k07e-138. Epub 2008 Jun 18. Endocr J. 2008. PMID: 18560201 Free article.
Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia).
Seino Y, Min KW, Niemoeller E, Takami A; EFC10887 GETGOAL-L Asia Study Investigators. Seino Y, et al. Diabetes Obes Metab. 2012 Oct;14(10):910-7. doi: 10.1111/j.1463-1326.2012.01618.x. Epub 2012 May 30. Diabetes Obes Metab. 2012. PMID: 22564709 Free PMC article. Clinical Trial.
Rationale, design, and baseline characteristics of a trial for the prevention of diabetic atherosclerosis using a DPP-4 inhibitor: the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A).
Katakami N, Mita T, Yoshii H, Onuma T, Kaneto H, Osonoi T, Shiraiwa T, Kosugi K, Umayahara Y, Yamamoto T, Yokoyama H, Kuribayashi N, Jinnouchi H, Gosho M, Watada H, Shimomura I; Collaborators on the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis Trial. Katakami N, et al. Among authors: shiraiwa t. J Atheroscler Thromb. 2013;20(12):893-902. doi: 10.5551/jat.18333. Epub 2013 Aug 20. J Atheroscler Thromb. 2013. PMID: 23965491 Free article. Clinical Trial.
Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE).
Mita T, Katakami N, Shiraiwa T, Yoshii H, Onuma T, Kuribayashi N, Osonoi T, Kaneto H, Kosugi K, Umayahara Y, Yamamoto T, Matsumoto K, Yokoyama H, Tsugawa M, Gosho M, Shimomura I, Watada H. Mita T, et al. Among authors: shiraiwa t. Diabetol Metab Syndr. 2014 Mar 10;6(1):35. doi: 10.1186/1758-5996-6-35. Diabetol Metab Syndr. 2014. PMID: 24607023 Free PMC article.
148 results